In last trading session, Fractyl Health Inc (NASDAQ:GUTS) saw 0.45 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $1.79 trading at -$0.03 or -1.65% at ring of the bell on the day assigns it a market valuation of $86.10M. That closing price of GUTS’s stock is at a discount of -710.06% from its 52-week high price of $14.50 and is indicating a premium of 2.79% from its 52-week low price of $1.74. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 360.38K if we extend that period to 3-months.
For Fractyl Health Inc (GUTS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.44 in the current quarter.
Fractyl Health Inc (NASDAQ:GUTS) trade information
Upright in the red during last session for losing -1.65%, in the last five days GUTS remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $1.79 price level, adding 16.55% to its value on the day. Fractyl Health Inc’s shares saw a change of -86.07% in year-to-date performance and have moved -12.25% in past 5-day. Fractyl Health Inc (NASDAQ:GUTS) showed a performance of -13.11% in past 30-days. Number of shares sold short was 2.24 million shares which calculate 5.48 days to cover the short interests.
Fractyl Health Inc (GUTS) estimates and forecasts
Statistics highlight that Fractyl Health Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -62.47% of value to its shares in past 6 months, showing an annual growth rate of 94.83% while that of industry is 16.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -16.67% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 10k for the same.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -126.07% during past 5 years.
On the other hand, iShares Russell 2000 ETF and MFS New Discovery Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024 , the former fund manager was holding 646.82 shares of worth $1.16 million or 1.34% of the total outstanding shares. The later fund manager was in possession of 639.15 shares on Aug 31, 2024 , making its stake of worth around $1.14 million in the company or a holder of 1.33% of company’s stock.
